Intus Bio develops biotechnology solutions centered on microbiome analysis and diagnostic discovery.
Intus Bio has raised $2.7M in total funding. The most recent round was Grant. The last funding was announced in September 2026.
Intus Bio's investors include Connecticut Innovations, UConn Innovation Fund - University of Connecticut, National Cancer Institute SBIR Development Center.
Intus Bio is headquartered in Farmington, United States.
Intus Bio develops biotechnology solutions centered on microbiome analysis and diagnostic discovery.
Intus Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Intus Bio — Funding & Investors." VCBacked, September 11, 2026, https://www.vcbacked.co/company/intus-bio. Accessed November 12, 2026.
VCBacked. (2026). Intus Bio — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/intus-bio
{{cite web |title=Intus Bio — Funding & Investors |url=https://www.vcbacked.co/company/intus-bio |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Intus Bio? Request a listing update